Investing Profile

Chris Leiter(146)

VCInvestorAngelFounder

Early stage investor in techbio

atria.vcSan Francisco, California
Photo of Chris Leiter, Atria Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Picture
Picture
Picture

11 Investors

Connected to Kevin Zhang (Upfront Ventures), Stonly Baptiste Blue (Third Sphere), Mark Suster (Upfront Ventures), and 8 other investors on Signal.

Massachusetts Institute of Technology Network
116 CONNECTIONS
The London School of Economics and Political Science (LSE) Network
29 CONNECTIONS
cb
$250K - $2.0M
$800K
13
CompanyStageDateRound SizeTotal Raised
Peptone
Seed RoundJan 2021€2M
€2M
Co-investors: Hussein Kanji (Hoxton Ventures)
Aspen RxHealth
Series BJan 2021$23M
$23M
Co-investors: Steve Kraus (Bessemer Venture Partners)
H1
Series BDec 2020$58M
$160M
Co-investors: Jared Kesselheim (Transformation Capital)
Pear Therapeutics
Series DDec 2020$80M
$80M
Co-investors: Elena Viboch (General Catalyst), Kirthiga Reddy (F7 Ventures)
Abridge
Series AOct 2020$10M
$28M
Co-investors: Andy Weissman (Union Square Ventures), Jamie Goldstein (Pillar VC), Esther Dyson
Freenome
Series CAug 2020$270M
$800M
Co-investors: Amir Nashat (Polaris Partners), Peter Kolchinsky (RA Capital), Jeffrey Schwartz (Bain Capital Life Sciences), Vasudev Bailey (Artis Ventures (AV)), Bill Maris (Section 32), Skip Fleshman (Asset Management Ventures)
Science 37
Venture RoundAug 2020$40M
$240M
Co-investors: Adam Goulburn (Lux Capital Management), Cris De Luca (Sanofi Ventures)
Thirty Madison
Series BAug 2020$47M
$190M
Co-investors: Amy Schulman (Polaris Partners)
Massachusetts Institute of Technology
The London School of Economics and Political Science (LSE)